Posted on December 10, 202412/10/24
Association Between Targeted Therapy and Survival in Patients with Myelodysplastic Syndromes
Posted on December 9, 202412/9/24
Association Between Targeted Therapy and Survival in Patients With Acute Myeloid Leukemia
Posted on November 26, 202411/26/24
The Importance of Quality-of-Life Metrics in mCRPC
Posted on November 6, 202411/6/24
Adherence Redefined: Evolving Approaches to Adherence in Oncology Clinical Pathways
Posted on November 4, 202411/4/24
Comparing First-Line Treatments for mCRPC: Insights From a Comprehensive NMA
Posted on September 27, 20249/27/24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Posted on September 9, 20249/9/24
Tumor Types Drive Oncology Product Launch Strategies
Posted on June 5, 20246/5/24
FDA Guidance and Considerations for Scientific Exchange Communication Strategies
Posted on March 12, 20243/12/24
Evolving Dynamics in Oncology: Considerations for Overcoming Commercialization Challenges and Driving Greater Impact
Posted on February 19, 20242/19/24